Matthew Gline

Matthew Gline is a seasoned executive with a robust foundation in both science and finance. At 40 years old as of July 26, 2024 , he initiated his academic journey by earning an A.B. in Physics from Harvard College, demonstrating strong analytical skills and a commitment to academic excellence.

Before his long tenure at ROIV, he cultivated a significant early career, holding roles that honed his expertise in financial markets. He served as a Vice President in the Fixed Income Digital Structuring group at Goldman Sachs from 2014 to 2016 and co-founded Fourthree, a technology and consulting firm in risk analytics.

Upon joining ROIV in March 2016, his career evolved rapidly. He initially contributed as the Senior Vice President of Finance and Business Operations, then advanced to the role of Chief Financial Officer in September 2017, and ultimately took the helm as Chief Executive Officer in January 2021. His strategic vision and leadership were further recognized with his appointment as a Director on the company's Board in September 2021.

Beyond his core responsibilities, he has played a pivotal role in setting the strategic direction for ROIV and has also contributed to the broader biopharmaceutical and healthcare sectors. Serving on the Board of Directors of Datavant, the world’s largest health data ecosystem, he continues to influence innovation and growth within the industry.

No information available on performance compensation for 2023.